TrademarkDir
Serial #98360616
LIVE

Serial Number

98360616

Owner

Neurocrine Biosciences, Inc.

Attorney

Allison Strickland Ricketts

Filing Date

Jan 17, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #98360616 Trademark

Serial Number: 98360616

Serial #98360616 is a trademark filed by Neurocrine Biosciences, Inc. on January 17, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

January 17, 2024

Registration Date

Not Registered

Published for Opposition

March 11, 2025

Goods & Services

Providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; Providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on line information services, namely, providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 29, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 28, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 13, 2025 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2025 EEXT
CORRECTED NOA E-MAILED
Nov 5, 2025 NOAC
DIVISIONAL PROCESSING COMPLETE
Nov 5, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 4, 2025 AITU
DIVISIONAL REQUEST RECEIVED
Aug 21, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Aug 21, 2025 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2025 PREV
ASSIGNED TO LIE
Feb 14, 2025 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 27, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 27, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRN
PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRA
PRIORITY ACTION WRITTEN
Aug 15, 2024 CPRA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 31, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 30, 2024 GPRN
PRIORITY ACTION E-MAILED
May 30, 2024 GPRA
PRIORITY ACTION WRITTEN
May 30, 2024 CPRA
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 5, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2024 NWOS
NEW APPLICATION ENTERED
Jan 17, 2024 NWAP

Related Trademarks

More from this Owner

DISCOVER CRENESSITY

DISCOVER CRENESSITY

DISCOVERCAH

DISCOVERCAH

THE SCIENCE OF FEELING ALIVE

THE SCIENCE OF FEELING ALIVE

GC OPTIMIZE

GC OPTIMIZE

NEUROCRINE

NEUROCRINE

MAKE THE SCREEN ROUTINE

MAKE THE SCREEN ROUTINE